Guardant Health, Inc. (GH)
NASDAQ: GH · IEX Real-Time Price · USD
28.87
+0.61 (2.16%)
At close: Jul 2, 2024, 4:00 PM
28.50
-0.37 (-1.28%)
After-hours: Jul 2, 2024, 6:17 PM EDT
Guardant Health Market Cap
Guardant Health has a market cap or net worth of $3.53 billion as of July 2, 2024. Its market cap has decreased by -3.24% in one year.
Market Cap
3.53B
Enterprise Value
3.72B
1-Year Change
-3.24%
Ranking
Category
Stock Price
$28.87
Market Cap Chart
Since October 4, 2018, Guardant Health's market cap has increased from $2.69B to $3.53B, an increase of 31.31%. That is a compound annual growth rate of 4.85%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 1, 2024 | 3.46B | 8.35% |
| Dec 29, 2023 | 3.19B | 14.55% |
| Dec 30, 2022 | 2.79B | -72.60% |
| Dec 31, 2021 | 10.17B | -21.09% |
| Dec 31, 2020 | 12.88B | 75.59% |
| Dec 31, 2019 | 7.34B | 127.63% |
| Dec 31, 2018 | 3.22B | 19.81% |
View and export this data all the way back to 2018.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Avidity Biosciences | 3.71B |
| Ultragenyx Pharmaceutical | 3.71B |
| Crinetics Pharmaceuticals | 3.59B |
| Waystar Holding | 3.58B |
| Perrigo Company | 3.54B |
| Merus | 3.52B |
| Axonics | 3.44B |
| Alvotech | 3.42B |